tiprankstipranks
Trending News
More News >
Positive Outlook for Liquidia Technologies Amid Legal Victories and Imminent PDUFA Date for Yutrepia
PremiumRatingsPositive Outlook for Liquidia Technologies Amid Legal Victories and Imminent PDUFA Date for Yutrepia
4d ago
Liquidia price target raised to $29 from $27 at Raymond James
Premium
The Fly
Liquidia price target raised to $29 from $27 at Raymond James
4d ago
Liquidia Corporation Awaits FDA Decision on YUTREPIA
Premium
Company Announcements
Liquidia Corporation Awaits FDA Decision on YUTREPIA
4d ago
Court dismisses United Therapeutics’ dispute against Liquidia
PremiumThe FlyCourt dismisses United Therapeutics’ dispute against Liquidia
11d ago
Positive Outlook for Liquidia Technologies: Buy Rating Affirmed Following Legal Victory and Anticipated FDA Approval
Premium
Ratings
Positive Outlook for Liquidia Technologies: Buy Rating Affirmed Following Legal Victory and Anticipated FDA Approval
11d ago
Liquidia rallies after judge rules against bid to delay Yutrepia
Premium
The Fly
Liquidia rallies after judge rules against bid to delay Yutrepia
11d ago
Liquidia Technologies: Buy Rating Affirmed Amidst Transformative Opportunities and Strategic Growth Potential
PremiumRatingsLiquidia Technologies: Buy Rating Affirmed Amidst Transformative Opportunities and Strategic Growth Potential
1M ago
Optimistic Buy Rating for Liquidia Technologies Driven by Yutrepia’s Regulatory Momentum and Promising Study Results
Premium
Ratings
Optimistic Buy Rating for Liquidia Technologies Driven by Yutrepia’s Regulatory Momentum and Promising Study Results
2M ago
Liquidia announces FDA acceptance of NDA resubmission for YUTREPIA
Premium
The Fly
Liquidia announces FDA acceptance of NDA resubmission for YUTREPIA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100